ARIAD to Present at Upcoming Investor Conferences
34th Annual Goldman Sachs Global Healthcare Conference William Blair 33rd
Annual Growth Stock Conference 2013
CAMBRIDGE, Mass. -- June 4, 2013
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will
provide an overview of the Company’s business at two upcoming investor
conferences being held next week:
*The William Blair Growth Stock Conference in Chicago. Timothy P. Clackson,
Ph.D., president of research and development and chief scientific officer,
will present on Tuesday, June 11 at 8:10 a.m. (CT).
*The Goldman Sachs 34th Annual Global Healthcare Conference in Rancho Palos
Verdes, CA. Harvey J. Berger, M.D., chairman and chief executive officer,
will present on Tuesday, June 11 at 2:40 p.m. (PT)
Both presentations will be webcast live and can be accessed by visiting the
investor relations section of the Company's website at
http://www.ariad.com/investor. A replay of the presentation will also be
available and archived on the site for three weeks.
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and
Lausanne, Switzerland, is an integrated global oncology company focused on
transforming the lives of cancer patients with breakthrough medicines. ARIAD
is working on new medicines to advance the treatment of various forms of
chronic and acute leukemia, lung cancer and other difficult-to-treat cancers.
ARIAD utilizes computational and structural approaches to design
small-molecule drugs that overcome resistance to existing cancer medicines.
For additional information, visit http://www.ariad.com or follow ARIAD on
ARIAD Pharmaceuticals, Inc.
Kendra Adams, 617-503-7028
Liza Heapes, 617-621-2315
Press spacebar to pause and continue. Press esc to stop.